检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:李晓燕[1] 潘莹[1] 魏雪[1] 刘韬[1] 黄红兵[1] LI Xiaoyan;PAN Ying;WEI Xue;LIU Tao;HUANG Hongbing(State Key Laboratory of Oncology in South China,Collaborative Innovation Center of Cancer Medicine,Sun Yat-sen University Cancer Center,Guangzhou 510060,China)
机构地区:[1]华南肿瘤学国家重点实验室,肿瘤医学协同创新中心,中山大学肿瘤防治中心,广州510060
出 处:《中国临床药学杂志》2022年第1期11-14,共4页Chinese Journal of Clinical Pharmacy
基 金:广东省医院药学研究基金(编号2020A14)。
摘 要:目的分析日间化疗中心患者使用聚乙二醇化重组人粒细胞刺激因子(PEG-rhG-CSF)的现状,为该药的管理提供参考数据。方法收集日间化疗中心在2019年5-7月使用PEG-rhG-CSF患者的病历资料,结合国内外指南及专家共识进行用药分析。结果日间化疗中心共254人340例次使用PEG-rhG-CSF,其中预防性使用305例次(89.71%),治疗性使用35例次(10.29%),均通过皮下注射给药,用药剂量分别为6 mg(84.41%)和3 mg(15.59%),剂量范围分别为69.36~166.2μg·kg^(-1)和34.09~83.33μg·kg^(-1)。预防性用药中,距上一程放化疗间隔符合指南标准的仅占27.87%。PEG-rhG-CSF距下一程放化疗<12 d及2次PEG-rhGCSF间隔<7 d分别占6.18%和1.29%。不良反应有白细胞增多、发热、疲乏和失眠。结论PEG-rhG-CSF在日间化疗中心以预防性使用为主,并存在一定的不合理现象,应重点关注距上一程放化疗间隔的问题。AIM To analyze the current situation of pegylated recombinant human granulocyte colonystimulating factor(PEG-rhG-CSF)for patients in the day-time chemotherapy center and provide reference data for the management of this drug.METHODS The medical records of patients,who used PEG-rhG-CSF in the day-time chemotherapy center from May to July 2019,were collected and analyzed based on domestic and foreign guidelines and expert consensus.RESULTS PEG-rhG-CSF was administrated subcutaneously in 254 patients for 340 times in the daytime chemotherapy center,among them 305 times(89.71%)for prophylactic use and 35 times(10.29%)for therapeutic use with the dosage of 6 mg(84.41%)and 3 mg(15.59%),and the dosage range was 69.36-166.2μg·kg^(-1) and 34.09-83.33μg·kg^(-1) respectively.Only 27.87%of the patients met the guidelines for the intervals from the previous course of chemoradiotherapy.The time intervals<12 d and<7 d were 6.18%and 1.29%respectively.Adverse reactions included leukocytosis,fever,fatigue,and insomnia.CONCLUSION PEG-rhG-CSF is mainly used for prophylaxis in the day-time chemotherapy center,and there is some unreasonable phenomena in use.Attention should be paid to the interval from the previous course of chemoradiotherapy.
关 键 词:聚乙二醇化重组人粒细胞刺激因子 日间化疗中心 用药间隔 不良反应
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.198